Inteliview
Log inSign up
IPO Tracker
R

Research Alliance Corp IV

Research Alliance Corp IV

USPricing
Valuation$75M
Original Target2026-06-08 (Date under review)
Sector--
Exchange--
RELATED IPOS
I
Iron Dome Acquisition I Corp.Iron Dome Acquisition I Corp.US · --
Onconetix, Inc.
Onconetix, Inc.Onconetix, Inc.US · --
A
Aperture ACAperture ACUS · --
HealthLynked Corp
HealthLynked CorpHealthLynked CorpUS · --
Picard Medical, Inc.
Picard Medical, Inc.Picard Medical, Inc.US · --
Solidion Technology Inc.
Solidion Technology Inc.Solidion Technology Inc.US · --
FAQ

When is the Research Alliance Corp IV IPO expected?

The Research Alliance Corp IV IPO is currently in the Pricing stage. The originally expected date was 2026-06-08 and the process is ongoing. Timelines may change based on market conditions.

What is Research Alliance Corp IV's valuation?

Research Alliance Corp IV's estimated valuation is approximately $75M. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the Research Alliance Corp IV IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.